Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | |
---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||
Cash from operating activities | 216.14%193.68M | -208.52%-166.76M | 273.56%153.67M | -141.23%-88.54M | 214.75M |
Net profit before non-cash adjustment | 178.50%112.95M | -284.31%-143.89M | 238.71%78.07M | -129.94%-56.28M | --187.95M |
Total adjustment of non-cash items | 123.85%63.65M | -17.02%28.43M | 65.41%34.27M | 25.05%20.72M | --16.57M |
-Depreciation and amortization | 28.64%57.91M | 45.72%45.02M | 32.42%30.89M | 97.50%23.33M | --11.81M |
-Disposal profit | ---2.9M | --0 | 101.34%167K | -1,952.82%-12.49M | --674K |
-Other non-cash items | 152.05%8.63M | -617.31%-16.59M | -67.53%3.21M | 142.03%9.88M | --4.08M |
Changes in working capital | 133.29%17.08M | -224.14%-51.31M | 178.01%41.33M | -617.59%-52.98M | --10.24M |
-Change in receivables | -170.57%-9.45M | -41.05%13.4M | 515.49%22.72M | -119.92%-5.47M | --27.46M |
-Change in inventory | 69.86%-2.49M | -236.37%-8.26M | 155.34%6.06M | ---10.95M | ---- |
-Change in prepaid assets | 123.25%12.79M | -693.95%-54.99M | 564.76%9.26M | 72.58%-1.99M | ---7.27M |
-Change in payables | 568.59%35.92M | -534.09%-7.67M | 104.99%1.77M | -449.68%-35.43M | --10.13M |
-Change in accrued expense | 23.87%1.47M | -39.72%1.19M | 167.35%1.97M | 60.93%-2.93M | ---7.5M |
-Provision for loans, leases and other losses | -4.53%6.41M | 166.57%6.72M | 3,214.47%2.52M | -98.97%76K | --7.37M |
-Changes in other current assets | -1,529.49%-27.57M | 43.03%-1.69M | -179.97%-2.97M | 122.44%3.71M | ---16.55M |
-Changes in other current liabilities | ---- | ---- | ---- | ---- | ---3.4M |
Dividends paid (cash flow from operating activities) | |||||
Dividends received (cash flow from operating activities) | |||||
Interest paid (cash flow from operating activities) | -2,173.91%-523K | 85.71%-23K | 82.73%-161K | 31.37%-932K | -1.36M |
Interest received (cash flow from operating activities) | 97,433.33%2.93M | 50.00%3K | 0.00%2K | 100.00%2K | 1K |
Tax refund paid | 126.17%5.51M | -516.79%-21.05M | 80.24%-3.41M | -6,639.02%-17.26M | 264K |
Other operating cash inflow (outflow) | 0 | 0 | 0.00%-1K | -200.00%-1K | 1K |
Operating cash flow | 207.33%201.59M | -225.14%-187.82M | 240.62%150.09M | -149.95%-106.73M | --213.66M |
Investing cash flow | |||||
Net PPE purchase and sale | 79.18%-2.71M | -1,014.07%-12.99M | -139.81%-1.17M | 118.38%2.93M | ---15.94M |
Net intangibles purchase and sale | -33.51%-81.66M | 17.15%-61.16M | -349.60%-73.82M | 73.19%-16.42M | ---61.25M |
Net business purchase and sale | --0 | ---14.5M | --0 | ---- | ---- |
Net changes in other investments | -2,390.91%-274K | -110.58%-11K | 101.23%104K | -219.96%-8.45M | ---2.64M |
Investing cash flow | 4.54%-84.64M | -18.40%-88.66M | -241.35%-74.88M | 72.52%-21.94M | ---79.83M |
Financing cash flow | |||||
Net issuance payments of debt | ---- | ---- | -200.00%-30M | 119.79%30M | ---151.63M |
Net common stock issuance | --0 | 42.42%142.42M | --100M | ---- | --165M |
Increase or decrease of lease financing | -4.67%-269K | -4.05%-257K | 98.28%-247K | -64.23%-14.35M | ---8.74M |
Net other fund-raising expenses | ---- | ---1K | ---- | 50.00%-1K | ---2K |
Financing cash flow | -100.19%-269K | 103.80%142.16M | 345.64%69.75M | 237.76%15.65M | --4.63M |
Net cash flow | |||||
Beginning cash position | -44.27%169.08M | 91.49%303.41M | -41.63%158.44M | 104.12%271.46M | --132.99M |
Current changes in cash | 186.86%116.68M | -192.66%-134.33M | 228.27%144.96M | -181.62%-113.02M | --138.47M |
Cash adjustments other than cash changes | ---- | ---1K | ---- | ---- | --2K |
End cash Position | 69.01%285.76M | -44.27%169.08M | 91.49%303.41M | -41.63%158.44M | --271.46M |
Free cash flow | 144.75%117.22M | -448.80%-261.98M | 160.99%75.11M | -191.25%-123.15M | --134.95M |
Currency Unit | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |